Details for New Drug Application (NDA): 216075
✉ Email this page to a colleague
The generic ingredient in GANIRELIX ACETATE is ganirelix acetate. There are four drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the ganirelix acetate profile page.
Summary for 216075
Tradename: | GANIRELIX ACETATE |
Applicant: | Lupin Ltd |
Ingredient: | ganirelix acetate |
Patents: | 0 |
Pharmacology for NDA: 216075
Mechanism of Action | Gonadotropin Releasing Hormone Receptor Antagonists |
Physiological Effect | Decreased GnRH Secretion |
Suppliers and Packaging for NDA: 216075
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
GANIRELIX ACETATE | ganirelix acetate | INJECTABLE;INJECTION | 216075 | ANDA | Lupin Pharmaceuticals, Inc. | 70748-274 | 70748-274-01 | 1 TRAY in 1 CARTON (70748-274-01) / 1 SYRINGE, GLASS in 1 TRAY / 1 mL in 1 SYRINGE, GLASS |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 250MCG/0.5ML | ||||
Approval Date: | Nov 16, 2023 | TE: | AP | RLD: | No |
Complete Access Available with Subscription